Hello, my name is Dr. Jessica Quimby,
and I'm an associate professor of
small animal internal medicine at the Ohio State University.
Today I'll be discussing the management of feline chronic kidney disease.
The framework in which I'd like to talk about the management of
feline chronic kidney disease is quite an important one for us as clinicians.
When we're speaking to our client's about chronic kidney disease with their cats,
it's really important to cultivate the bond with the client and also to really
explain what the various therapies we might
be prescribing for chronic kidney disease are.
If the client does not understand why we're giving a particular medication,
it's possible that the treatment plan will fail.
Cats can be quite challenging patients in
the veterinary setting because sometimes it can be difficult to give them medications.
It's quite important that we consider the balance
between quality of life and the therapies that we might be prescribing.
Therefore, we typically have a fairly extended conversation with
owners about whether or not they can actually give a medication,
a pill or for instance,
subcutaneous fluids to the patient.
We'll be trying to create the best plan for that patient for management of their disease.
With that in mind, it may be necessary to prioritize
treatments and determine which ones might be best for that particular patient,
depending on the different complications of chronic kidney disease
that might be manifesting with their particular disease.
With this in mind, I'd like to introduce the concept of
evidence-based medicine as it applies to the management of feline chronic kidney disease.
We typically utilize different scales of evidence-based medicine to better define
what type of studies have been done to
tell us whether a specific therapy for the disease is effective.
Throughout this presentation, you'll see small icons on the slides that will
give you an idea of what evidence we have for a particular treatment.
Whether it's a randomized controlled clinical study
or whether it's a weaker grade of evidence where
our recommendations for a particular therapy are based
more on opinions or pathophysiologic concepts,
and we don't actually have a clinical study for
that particular therapy in the cat as a chronic kidney disease patient.